GHK-Cu

GHK-Cu, or glycyl-L-histidyl-L-lysine copper, is a naturally occurring complex of copper and a tripeptide. It is studied in skin, fibroblasts, extracellular matrix and wound biology. Some evidence comes from cell and animal models, while human studies are usually small and relate mainly to topical cosmetic use.

Much of the scientific interest concerns skin and connective tissue. Experimental studies suggest that GHK-Cu can influence dermal fibroblast activity and increase synthesis of collagen, elastin and glycosaminoglycans. These structures are important for skin firmness, elasticity and normal tissue repair. GHK-Cu also participates in extracellular-matrix remodelling, the process through which damaged tissue is reorganised and replaced. These properties have made it a long-standing subject in cosmetic and wound-healing research.

Another area of study is regulation of inflammation. Laboratory and animal models have reported reduced oxidative stress, lower accumulation of reactive oxygen species and decreased expression of inflammatory cytokines such as TNF-α and IL-6. These effects have been linked to NF-κB and other inflammatory signalling pathways. Because chronic inflammation contributes to tissue ageing, GHK-Cu is often investigated as a possible modulator of tissue-protection mechanisms. Most of this evidence remains preclinical and cannot be transferred directly to humans.

GHK-Cu is relatively well documented in experimental wound-healing research. Animal studies have reported faster formation of granulation tissue, promotion of new blood-vessel growth, increased fibroblast proliferation and earlier epithelialisation. In some models, treated wounds closed more quickly than controls and showed lower inflammation and improved collagen organisation. These findings explain the continuing research interest in GHK-Cu within tissue-regeneration models.

More recent work has examined possible effects on gene expression. Bioinformatic analyses suggest that GHK-Cu may influence the activity of hundreds of genes, promoting pathways associated with repair while reducing signals linked with chronic inflammation, oxidative stress and tissue degradation. This broad proposed pattern distinguishes it from compounds that act primarily through one receptor or a single biological pathway.

The literature also explores GHK-Cu in hair-follicle, nervous-system, lung, liver and bone-regeneration models. Results in several of these areas are scientifically interesting, but the evidence is largely experimental. The compound therefore remains an active research subject whose biological potential is still being defined.

GHK-Cu has a plausible biochemical relationship with copper transport, matrix remodelling and skin biology, but the strength of evidence differs substantially by application. Small topical studies cannot establish broad systemic effects, reliable hair growth or longevity benefits. Such claims would require larger, independent and well-controlled clinical trials.